• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Theranica Bio-Electronics

Theranica lands VA contract for migraine device

February 16, 2021 By Nancy Crotti

Theranica announced today that it has signed a contract to supply its Nerivio device to the U.S. Department of Veterans Affairs (VA) for use by veterans who suffer from chronic migraine headaches. Nerivio is worn on the upper arm for 45 minutes and uses remote electrical neuromodulation to activate the brain’s native conditioned pain modulation […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Featured Tagged With: Theranica Bio-Electronics, U.S. Department of Veterans Affairs

FDA clears Theranica device for adolescent migraines

January 25, 2021 By Nancy Crotti

Theranica announced today that the FDA has granted expanded clearance for the use of its Nerivio acute migraine treatment device by people 12 years and older. The use of the device in the treatment of adolescents is supported by a study recently published in Headache. According to the study, 28 of 39 (71%) of the adolescent participants using […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Neurological, Neuromodulation/Neurostimulation, Pain Management, Regulatory/Compliance Tagged With: FDA, Theranica Bio-Electronics

Ambu, Boston Sci execs see domination for single-use scopes

September 11, 2020 By Tom Salemi

Hospital closures connected to COVID-19 have cut into the sales of many medical device companies, but executives at rival makers of single-use scopes say pandemic has only heightened existing concerns about contamination, exposure and cost. In interviews in this week’s DeviceTalks Weekly Podcast, executives from Ambu A/S  and Boston Scientific (NYSE:BSX)  said improved technology make […]

Filed Under: Endoscopic, Featured Tagged With: Ambu, Bardy Diagnostics, Boston Scientific, Centers for Medicare and Medicaid Services (CMS), CMS, Donald Trump, Elizabeth Holmes, Joe Biden, Kevin Hykes, Theranica Bio-Electronics, Theranos

The top 5 MassDevice stories of the week — September 11, 2020

September 11, 2020 By Chris Newmarker

From the Theranos case to wearable medical devices, it’s been another busy news week for the medical device industry. Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top Five: […]

Filed Under: Business/Financial News, Featured, Legal News, Pharmaceutical Tagged With: Bardy Diagnostics, coronavirus, COVID-19, Donald Trump, Elizabeth Holmes, Joe Biden, MassDevice Top Five, Theranica Bio-Electronics, Theranos

Theranica lands CE mark for migraine device

September 8, 2020 By Sean Whooley

Theranica announced today that it received CE Mark approval for its Nerivio device for the acute treatment of migraine. Montclair, N.J.-based Theranica adds European approval just over a year since it received FDA de novo clearance for the neurostimulation device in May 2019. The approval allows for the company to begin marketing the device in […]

Filed Under: Health Technology, Neurological, Neuromodulation/Neurostimulation, Pain Management, Software / IT Tagged With: CE Mark, Theranica Bio-Electronics

Theranica wins de novo FDA clearance for migraine armband

May 28, 2019 By Fink Densford

Theranica said today that it won FDA de novo clearance for its Nerivio Migra remote electrical neuromodulation system intended for the acute treatment of migraines. The approval came based off a prospective, randomized, double-blind, placebo-controlled, multi-center pivotal study of 252 patients, the Israel-based company said. Data from the study was published in Headache: The Journal of […]

Filed Under: Food & Drug Administration (FDA), Neurological, Regulatory/Compliance Tagged With: Theranica Bio-Electronics

Omron joins $35m Theranica Series B

May 13, 2019 By Fink Densford

Theranica said today that Omron‘s (TYO:6645) venture arm joined a $35 million Series B financing round to support its remote neuromodulation technology. Israel-based Theranica is developing the Nerivio Migra neurostimulation patch intended to treat migraine headache, which is currently under FDA review. Funding in the round, which was initially announced in March, was led by […]

Filed Under: Business/Financial News, Neurological, Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: Omron, Theranica Bio-Electronics

Theranica raises $35m Series B for neuromod migraine patch

March 19, 2019 By Brad Perriello

Theranica Bio-Electronics said yesterday that it raised a $35 million Series B round for the Nerivio Migra neurostim patch it’s developing to treat migraine headache. Netanya, Israel-based Theranica said VC shop aMoon led the round, joined by all of its existing backers, Lightspeed Venture Partners, LionBird, Corundum Open Innovation and Takoa. The company raised an […]

Filed Under: Featured, Funding Roundup, Neuromodulation/Neurostimulation, Pain Management, Wall Street Beat Tagged With: Theranica Bio-Electronics

Theranica raises seed round for Nerivio Migra wearable migraine device

September 20, 2016 By Fink Densford

Newly-formed med device company Theranica Bio-Electronics said today it closed a seed financing round led by Dr. Shimon Eckhouse and joined by a group of angel investors. The company did not release the amount raised in the round. Israel-based Theranica is developing the Nerivio Migra, a disposable neuromodulation patch designed to treat migraine headaches. “Theranica […]

Filed Under: Neuromodulation/Neurostimulation, Pain Management Tagged With: Theranica Bio-Electronics

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy